KRAS and melanoma: We therefore examined the impact of PLX4032 and MEKi on RHOB expression in wild type BRAF melanoma cells harboring mutations in NRAS (WM1346 and SK-MEL2 cells), KIT (WM3211 cells) or KRAS (WM1791C cells).